M. Miravitlles (Barcelona, Spain), S. Sethi (Buffalo, United States of America)
MR-proANP predicts 2-year survival in patients admitted for acute exacerbation of COPD
M. Bernasconi, M. Christ-Crain, C. Müller, B. Müller, M. Tamm, D. Stolz (Basel, Switzerland)
|  |
Mechanisms of persistence of Streptococcus pneumoniae following treatment of acute exacerbation of chronic bronchitis
H. Desai, A. Johnson, T. Murphy, S. Sethi (Buffalo, United States Of America)
|  |
Wu polyomavirus DNA is not detectable in respiratory secretions from adults with acute exacerbation of COPD
F. C. Ringshausen, M. Heckmann, I. Borg, U. Arinir, J. Kronsbein, B. M. Hauptmeier, G. Schultze-Werninghaus, G. Rohde (Bochum, Germany; Bülach, Switzerland)
|  |
Viral infections as a cause of chronic obstructive pulmonary disease (COPD) exacerbations
O. Kherad, L. Kaiser, F. Sarasin, O. Rutschmann, J. P. Janssens (Geneva, Switzerland)
| |
Effects of colonization by Haemophilus influenzae in COPD stable patients
A. Marín-Tapia, J. García-Aymerich, E. Monsó, J. Sauleda, F. Gómez, M. García, J. M. Antó, PAC-COPD Study Group (Babalona, Barcelona, Palma de Mallorca, Spain)
| |
Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone (SFC)
M. Cazzola, P. Noschese, F. Di Perna (Rome, Naples, Caserta, Italy)
| |
Antibiotics reduce dual pathogen isolates more than single pathogen isolates following COPD exacerbation
J. Goldring, G. Donaldson, J. Quint, R. Baghai-Ravary, J. Wedzicha (London, United Kingdom)
| |
Molecular epidemiology of acute exacerbations of chronic bronchitis (AECB)
M. Lerikou, S. Tsiodras, P. Karakitsos, A. Chranioti, E. Perros, O. Anagnostopoulou, G. Dimopoulos (Athens, Greece)
| |